Name Card
Emeritus Professor Lam, Karen Siu Ling 林小玲
Title:
Honorary Clinical Professor
Director of Clinical Operations, HKU Health System
Department:
Faculty:
Knowledge Exchange Activities
| Activity Title | Activity Type | Start Date | End Date | Member(s) | |
|---|---|---|---|---|---|
| 2015/16 KE Impact Project Funding: KE-IP-2015/16-46: Lifestyle Modification for adults with pre-diabetes: A follow-up of the HKU DRS app users (HK$68,850) | KE Project Grant | 2015-08-07 | 2016-06-30 | ||
| Phase 1 centre press conference | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2015-06-03 | 2015-06-03 | Leung Roland Ching Yu | |
| HKU developed a mobile app for testing diabetes risk | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2014-08-27 | 2014-08-28 | Yeung Chi Keung | |
| An app testing the risk of diabetes | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2014-08-27 | 2014-08-28 | Yeung Chi Keung | |
| Professional drivers are in lack of exercise: high risk group of diabetes | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2014-08-27 | 2014-08-28 | Yeung Chi Keung | |
| Diabetes risk rating on line | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2014-08-27 | 2014-08-28 | Yeung Chi Keung | |
| Diabetes Risk Score smartphone application (DRS app): its application in diabetes prevention and health education | KE Website and Mobile Device | 2013-08-19 | 2014-06-30 | Cheung Mike Kwun Ting | |
| Diabetes Education and Management Course 2013 | Short Course for Continuing Professional Development (CPD) | 2013-02-26 | 2013-04-30 | ||
| RGC Public Lecture on Obesity | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2013-04-06 | 2013-04-06 | ||
| 2013/14 KE Impact Project Funding: KE-IP-2013/14-41: Diabetes Risk Score smartphone application (DRS app): its application in diabetes prevention and health education | KE Project Grant | 2013-08-19 | 2014-06-30 | Cheung Mike Kwun Ting | |
| 港大醫學院開發納米藥物遞送系統 有助治療肥胖及動脈粥樣硬化 | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2023-02-16 | 2023-02-16 | Chen Kang Cheong Lai Yee Wang Qin Jin Leigang | |
| An app testing the risk of diabetes | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2014-08-27 | 2014-08-28 | Yeung Chi Keung | |
| HKU developed a mobile app for testing diabetes risk | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2014-08-27 | 2014-08-28 | Yeung Chi Keung | |
| Diabetes risk rating on line | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2014-08-27 | 2014-08-28 | Yeung Chi Keung | |
| Professional drivers are in lack of exercise: high risk group of diabetes | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2014-08-27 | 2014-08-28 | Yeung Chi Keung | |
| HKUMed discovers a novel mediator of liver fibrosis and its underlying mechanism that can be a new therapeutic target | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2021-04-12 | 2021-04-12 | Zhang Zixuan Zong Jiyu Shu Lingling Ye Dewei Song Erfei Li Jingjing | |
| HKUMed discovers a novel mediator of cerebral ischaemia injury and its underlying mechanism which can be a new therapeutic target for ischaemic stroke | Other KE Activity Types | 2020-06-03 | 2020-06-03 | Liao Boya Shu Lingling Chung Sookja K Yeung Patrick Chang Junlei Wei Ling Zhang Fang Vanhoutte M Paul Wang Kai | |
| 港大發現新調節因子 有望進一步了解肝纖維化形成機制 (Headline Daily Instant News) | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2021-04-12 | 2021-04-12 | Zhang Zixuan Zong Jiuyu Li Jingjing Shu Lingling | |
| • 港大研究｜肝纖維化病理機制研究現突破 脂肪因子A-FABP 成新治療靶點助研藥; Sky Post Instant News | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2021-04-13 | 2021-04-13 | Zhang Zixuan Zong Jiuyu Li Jingjing Shu Lingling | |
| Development of the Hong Kong Cardiovascular Risk Factor Prevalence Study Health Risk Engines Smartphone App for Better Cardio-metabolic Health in the Community | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2020-04-01 | 2020-09-15 | Fong Ho Yi Wan Yilin Chau Wing Ki Woo Yu Cho | |
| 港大發現新調節因子 有望進一步了解肝纖維化形成機制 (Bastille Post) | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2021-04-12 | 2021-04-12 | Zhang Zixuan Zong Jiuyu Li Jingjing | |
| 港大醫學院揭體內蛋白可致肝纖維化 研藥物針對「靶點」可望斷尾 (HK01) | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2021-04-12 | 2021-04-12 | Zhang Zixuan Zong Jiuyu Li Jingjing Shu Lingling | |
| 港大發現調節因子或能進一步了解肝纖維化形成機制 | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2021-04-12 | 2021-04-12 | Zhang Zixuan Zong Jiyu Li Jingjing Shu Lingling Ye Dewei Song Erfei | |
| 【港大研究】港大發現調節細胞互動能減少術後肝纖維化 或有助降低患肝硬化肝癌風險 (Topick.hket.com) | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2021-04-13 | 2021-04-13 | Zhang Zixuan Zong Jiuyu Li Jingjing Shu Lingling | |
| 【肝纖維化治療】肝纖維化可致肝癌 港大發現新致病因子助研新治療靶點; Urbanlifehk.com | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2021-04-13 | 2021-04-13 | Zhang Zixuan Zong Jiuyu Li Jingjing Shu Lingling | |
| 港大醫學院揭體內蛋白可致肝纖維化 研藥物針對「靶點」可望斷尾; Chineseineurope.com | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2021-04-13 | 2021-04-13 | Zhang Zixuan Zong Jiuyu Li Jingjing Shu Lingling | |
| The 13th AHKDN Webinar Annual General Meeting & Evidence-based Practice Symposium | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2021-06-26 | 2021-06-26 | ||
| patient Information sheet for Primary Aldosteronism | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2015-09-01 | 2015-12-30 | Yuen Mae Ann Michele | |
| Interview by MIMS Doctors on"Hong Kong's footprint in global medical advances: Past, present and future" | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2015-07-02 | 2015-07-02 | Chu Leung Wing | |
| Diabetes Education and Management Course | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2016-04-19 | 2016-06-21 | ||
| patient Information sheet for Cushing's Syndrome | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2015-09-01 | 2015-12-30 | Yuen Mae Ann Michele | |
| Interview by Lancet DM & Endocrinology Hong Kong Edition | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2015-10-13 | 2015-10-13 | ||
| Interview by Oriental Daily on "香港大學李嘉誠醫學院內科學系 - 香港醫學論壇二十周年系列 : 香港大學內分泌科 –從基礎研究到臨床應用" | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2015-02-28 | 2015-02-28 | ||
| Shooting of an episode of Pearl Reoport on "Clinical Trials in Hong Kong" | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2015-07-02 | 2015-07-27 | ||
| Update on Diabetes Management (A Certificate Course for Clinicians) | Short Course for Continuing Professional Development (CPD) | 2015-10-31 | 2015-11-01 | ||
| New Population-Based Cardiovascular Risk Factor Prevalence Study (N-CRISPS) | KE Website and Mobile Device | 2019-08-01 | 2024-09-30 | Fong Ho Yi Woo Yu Cho Woo J | |
| Facebook page on New Population-Based Cardiovascular Risk Factor Prevalence Study (N-CRISPS) | KE Website and Mobile Device | 2019-08-14 | 2024-09-30 | Fong Ho Yi Woo Yu Cho | |
| the 4th China Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2017-05-11 | 2017-05-13 | ||
| Diabetes Education & Management Course | Other KE Activity Types | 2018-04-24 | 2018-04-24 | ||
| Diabetes Education and Management Course | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2021-06-01 | 2021-08-10 | ||
| National Diabetes Institute 16th Continuing Professorial Development Series: Diabetes Asia 2017 Conference, Kuala Lumpur, Malaysia | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2017-10-11 | 2017-10-14 | ||
| Special Funding for Impact Evidence Collection: KE-SR-2017/18-2: Impact Evidence Collection for Units of Assessment in the Li Ka Shing Faculty of Medicine (HK$1,700,000) | KE Project Grant | 2018-03-20 | 2019-06-30 | Liu Chi Leung Lam Ka Wai Katherine | |
| Gold medal award at the 47th International Exhibition of Inventions of Geneva | KE Award/Prize on KE Achievement | 2019-04-10 | 2019-04-14 | Zhong Ling | |
| HK Women Professional & Entrepreneurs Association Inspiring Leadership Lunch Series: #1 Dare to Lead | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2019-06-26 | 2019-06-26 | ||
| Diabetes Education & Management Course | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2019-04-30 | 2019-04-30 |
Invited Lectures & Keynote Speeches
| Title | Conference | Date |
|---|---|---|
| Development of Diabetes Nursing in Hong Kong | The 2nd AHKDN Evidenced-based Practice Symposium | 2021-06-01 |
| Meeting the Challenges of Diabetes and Its Complications | 25th Hong Kong Medical Forum | 2020-05-01 |
| FGF21 mediates the inter-talk between major metabolic regulators | Asian and Oceanian Physiological Societies Congress (FAOPS) 2019. Kobe, Japan | 2019-03-01 |
| FGF21: a multifarious regulator of glucose metabolism. (Plenary Lecture) | Asia Islet Biology & Incretin Symposium (AIBIS), Seoul, 2-4 Aug 2018 | 2018-08-01 |
| FGF21: a multifarious regulator of glucose metabolism | Asia Islet Biology & Incretin Symposium (AIBIS), Seoul | 2018-08-01 |
| A novel biomarker predictive of clinical outcomes in type 2 diabetes | Xi Jing Diabetes and Endocrine Forum, Xian | 2018-06-01 |
| A novel biomarker predictive of clinical outcomes in type 2 diabetes. (Keynote Lecture) | Xi Jing Diabetes and Endocrine Forum, Xian, 29 Jun – 1 Jul 2018 | 2018-06-01 |
| A novel prognostic marker of diabetic complications | Guangdong Hong Kong Macau Bay Area Endocrine Forum, Guangzhou | 2018-03-01 |
| The new development of T2DM management | AstraZenica Diabetes Summit-Guangzhou | 2018-03-01 |
| FGF21, Diabetes & Diabetic Complications: Clinical Perspectives | Diabetes Asia 2017 Conference, Kuala Lumpur | 2017-10-01 |
| Strategies to Have Patients More Compliant to Treatment | Diabetes Asia 2017 Conference, Kuala Lumpur | 2017-10-01 |
| Non-alcoholic Fatty Liver Disease in Diabetic Patients: Challenges & Opportunities | Diabetes Asia 2017 Conference, Kuala Lumpur | 2017-10-01 |
| Adipocyte fatty acid binding protein mediates ischemic stroke | Mini-symposium on brain and adipose tissue crosstalk 2017 | 2017-08-01 |
| FGF21 as a novel metabolic hormone: clinical implication | Guangzhou-Hong Kong Diabetes Forum | 2017-05-01 |
| SGLT-2 Inhibitor In Clinical Practice—Asian Data And Experience Sharing | 4th China Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) 11-13 May 2017, Shanghai | 2017-05-01 |
| Hyperaldosteronism – Review - Is it common? | 4th China Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) 11-13 May 2017, Shanghai | 2017-05-01 |
| Adipocyte Fatty Acid Binding Protein (A-FABP) in obesity and its related complications: Friend or Foe? | 4th Lingnan International Symposium of Metabolic Diseases: Frontiers in Immunometabolism | 2017-02-01 |
| Inflammation and atherosclerosis: role of adipokines | 5th International Congress on Lipid Metabolism &Atherosclerosis (ICLA 2016), September 9~10, 2016, Korea | 2016-09-01 |
| Optimising oral anti-diabetic agents in the management of type 2 diabetes | 18th ASEAN Federation Endocrine Society (AFES) Congress Kuala Lumpur, 10-13th Dec 2015, Kuala Lumpur, Malaysia | 2015-12-01 |
| Clinical strategies in managing dysglycaemia in endocrine disorders | 18th ASEAN Federation Endocrine Society (AFES) Congress Kuala Lumpur, 10-13th Dec 2015, Kuala Lumpur, Malaysia | 2015-12-01 |
| Adiponectin in diabetes and its multifarious complications (Plenary) | 9th Huaxia International Congress of Endocrinology, 12-13 Dec 2015, Taipei | 2015-12-01 |
| Insights on the Roles of Adipokines in Clinical Diabetes (Plenary Lecture) | 7th Asian Association for the Study of Diabetes Scientific Meeting and Annual Scientific Meeting of the Hong Kong Society of Endocrinology, Metabolism and Reproduction. | 2015-11-01 |
| Insights on the Roles of Adipokines in Clinical Diabetes. (Plenary) | 7th Asian Association for the Study of Diabetes Scientific Meeting and Annual Scientific Meeting of the Hong Kong Society of Endocrinology, Metabolism and Reproduction, 21-22 Nov 2015, Hong Kong | 2015-11-01 |
| Markers for diabetic nephropathy | International Conference on Diabetes and Metabolism, 15-17 Oct 2015, Jeju Island, Korea | 2015-10-01 |
| Adipocyte fatty acid binding protein (A-FABP) potentiates toxic lipids-induced endoplasmic reticulum stress and inflammation in macrophages via inhibition of Janus Kinase 2-dependent autophagy | 2015-08-01 | |
| A-FABP is a potential mediator of diabetic cardiomyopathy and ischemic reperfusion induced cardiac injury | Journal of the Hong Kong College of Cardiology ISSN: 1027-7811 | 2014-11-01 |
| Support Program for People with Diabetes in the Community: Experience from Hong Kong | 13th Continuing Professional Development Series: “Diabetes Asia 2014” Conference, 16-19 Oct 2014, Kuala Lumpur | 2014-10-01 |
| Adiponectin, Diabetes and Diabetic Complications. (Plenary lecture) | 13th Continuing Professional Development Series: “Diabetes Asia 2014” Conference, 16-19 Oct 2014, Kuala Lumpur | 2014-10-01 |
| Endocrinology & diabetes training in UK and Hong Kong | The Annual Congress of the Chinese Endocrinologist Association of Chinese Medical Doctor Association, 10-12 July, Xiamen, China | 2014-07-01 |
| Liver-brain inter-talk in glucose homeostasis: role of FGF21 | 2014 Seoul International Congress of Endocrinology and Metabolism, 16-18 May, Seoul | 2014-05-01 |
| FGF21 as a novel metabolic hormone | The 7th Oriental Congress of Endocrinology and Metabolism, 18-20 April 2014, Shanghai | 2014-04-01 |
| Risk of diabetes in relation to fat distribution: the Asian region experience | Obesity Reviews ISSN: 1467-7881 ; eISSN: 1467-789X | 2014-03-01 |
| Adipocyte fatty acid binding protein potentiates palmitic acid induced endoplasmic reticulum stress in macrophages via inhibition of Janus kinase 2-dependent autophagy | Singapore Diabetes Forum 2014 | 2014-01-01 |
| The impact of ageing on diabetes and our future needs | IDF World Diabetes Congress, 2-6 Dec 2013, Melbourne, Australia | 2013-12-01 |
| FGF21 as an emerging metabolic regulator | Annual Scientific Meeting of the Endocrine Society of the Republic of China, 16-17 Nov 2013, Taipei, Taiwan | 2013-11-01 |
| Diabetes & Cardiovascular Risks – Are we doing enough? | FOCUS on CVM, 26-27 Oct 2013, Bali, Indonesia | 2013-10-01 |
| Macrovascular disease in diabetes: Opportunities for lipid management | Cardiovascular Risk Master Class of the Physicians Academy for Cardiovascular Education (PACE) Foundation, Kuala Lumpur, Malaysia | 2013-05-01 |
| The role of initial dual therapy in diabetes treatment | FOCUS on CVM, 26-27 Oct 2013, Bali, Indonesia | 2013-05-01 |
| Adipocyte fatty acid binding protein in the pathogenesis of obesity-related nonalcoholic steatohepatitis | APDO 2013, Tokyo, Japan | 2013-04-01 |
| An effective fraction isolated from Radix Astragali alleviates glucose tolerance, insulin resistance and hypertriglyceridemia in db/db diabetic mice through its anti-inflammatory activity | The 5th International Conference on Diabetes, Teaching Hospital of Chengdu Unviersity of Traditional Chinese Medicine | 2012-04-01 |
| The Role of Adipocyte Fatty Acid Binding Protein (A-FABP) in the Pathogenesis of Obesity-related Inflammatory Diseases. | Sixth International Symposium on Healthy Aging, 2011. | 2011-10-01 |
| Update on the pathophysiology and genetics of diabetes | Annual Scientific Meeting of the Hong Kong Society of Clinical Chemistry | 2011-01-01 |
| Adipocyte-FABP as a novel biomarker predicting the development of cardiometabolic diseases | Cardiovascular and Metabolic Disease Leaders Summit, Beijing, China | 2010-09-01 |
| Incretin and islet biology: Basic science within Merck | Asia Islet Biology & Incretin symposium, Kyoto, Japan | 2010-08-01 |
| Fibroblast growth factor 21 as a novel metabolic hormone integrating the circadian rhythm with energy homeostasis in man | The 6th Scientific Meeting of the Asia-Pacific Diabetes and Obesity Study Group, Singapore | 2010-08-01 |
| Fighting the obesity epidemic - What’s on the horizon? | The 1st Richard Yu Lecture in Medicine, Medical Forum, University of Hong Kong | 2010-05-01 |
| Amyloid Beta Neurotoxicity | Frontiers in Biomedical Research HKU 2009 | 2009-12-01 |
| Glucotoxicity vs liptoxicity: Impact on islet pathophysiology – β-cell mass and function (Plenary lecture) | 2nd Asia Islet biology & Incretin Symposium, Seoul, Korea | 2009-04-01 |
| Protective roles of adiponectin in obesity-related fatty liver diseases: Mechanisms and Therapeutic Interventions | the International Society for Endocrinology meeting | 2008-11-01 |
| Clinical perspective on DPP-IV inhibitors | 1st Scientific Meeting of the Kang-buk diabetes Center, Samsung Medical Center Hospital, Korea | 2008-10-01 |
| Identification of two natural compounds from traditional Chinese medicine that increase adiponectin production by adipocytes and alleviate diabetes in mice | The 4th Scientific Meeting of Asia-Pacific Diabetes and Obesity Study Group, Kobe, Japan | 2008-08-01 |
| Structural Mechanisms underlying the Inhibitory Effects of Angiopoietin-like Protein 4 on Lipoprotein Lipase Activities | 4th Scientific Meeting ofAsia-Pacific Diabetes and Obesity Study Group | 2008-08-01 |
| A new approach for type 2 diabetes therapy | Diabetes, Obesity & Cardiovascular: The Link and the Future, Indonesia | 2008-07-01 |
| Adipokines at the crossroad of obesity, inflammation and type 2 diabetes | The 2008 annual international meeting of Korean Endocrine Society | 2008-05-01 |
| Obesity and cardiometabolic risk in diabetes. (Keynote lecture) | 7th IDF-WPR Congress, Wellington, New Zealand | 2008-04-01 |
| Advances in the management of diabetes. (Plenary lecture) | 1st Beijing-Hong Kong Medical Forum, Beijing, China | 2008-04-01 |
| Novel adipokines in the prediction and treatment of cardiometabolic risk. | 2007 Annual Symposium of Korean Society for the Study of Obesity, Seoul, Korea | 2007-11-01 |
| Predicting the development of diabetes in Hong Kong Chinese. | Seoul Diabetes Forum, Seoul, Korea | 2007-11-01 |
| Diabetes in Chinese: Changing Epidemiology, Prediction and Preventive Measures. | Magnuson Congress, Seattle, USA | 2007-10-01 |
| Targeting the endocannabinoid system to manage cardiometabolic risk. | Targeting the endocannabinoid system to manage cardiometabolic risk. Rimonabant: A novel approach to cardiometabolic risk management, Singapore | 2007-05-01 |
| The emerging concept of cardio-metabolic risk. | Vascular Event ’07, Sydney, Australia | 2007-04-01 |
| Diabetes in Chinese: Changing epidemiology and novel biomarkers. | MGH-HKU-Nature China Forum, Hong Kong | 2007-03-01 |
| The role of incretins in maintianing physilogic glucose control: effects of insulin and glucagons. | 4th International Huaxia Congress, Hong Kong | 2006-12-01 |
| Integrating the Professional and Non-professional Organisations: the Optimal Model | 19th World Diabetes Congress, Cape Town, South Africa | 2006-12-01 |
| The Endocannabinoid system and its role in the pathogenesis of cardiometabolic disease. | Korean Society for the Study of Obesity, 2006 Scientific Meeting, Seoul, Korea | 2006-09-01 |
| Adipocyte fatty acid binding protein as a novel player in the metabolic syndrome: clinical and functional studies. | 2nd Scientific Meeting of the Asia-Pacific Diabetes and Obesity Study Group, Kobe, Japan | 2006-08-01 |
| Pleuripotency of Adiponectin – insights from animal studies | 7th Molecular Diabetology in Asia, Hong Kong | 2005-12-11 |
| Current Diabetes Management in Asia: New Concepts, New Tools | Asean Federation of Endocrine Societies (AFES) Congress 2005, Manila, Philippines | 2005-12-10 |
| Role of Incretins in Glucose Homeostasis and β-cell Function | Asean Federation of Endocrine Societies (AFES) Congress 2005, Manila, Philippines | 2005-12-09 |
| Fat cells & heart disease | Frontiers in Biomedical Research – Clinical Application, Beijing, China | 2004-12-15 |
| Adipokines, metabolic syndrome and cardiovascular diseases | 10th SCBA (Society of Chinese Bioscientists in America) International Symposium, Beijing, China | 2004-07-25 |
| Fat cells, metabolic syndrome & heart disease” Plenary lecture | 3rd International Huaxia Congress of Endocrinology, Shanghai, China | 2004-05-27 |
| The metabolic syndrome: Clinical implications and management | 8th Asian Pacific Congress of Cardiac Rehabilitation, Hong Kong | 2003-12-14 |
| Identifying cardiovascular risk in patients: the Asian experience with diabetes | MSD Speakers Forum, Bangkok, Thailand | 2003-10-26 |
| Obesity as a key player in the Metabolic Syndrome | 13th International Symposium on Atherosclerosis, Kyoto, Japan | 2003-09-30 |
| Hormones as Anti-Ageing Agents | 8th Hong Kong Medical Forum | 2003-07-06 |
| Genetics of early onset type 2 diabetes in southern Chinese | 2nd Sino-American Medical Symposium, Shanghai, China | 2002-10-10 |
| Reducing diabetes risk by treating obesity | IOTF Special Symposium, 3rd World Congress on Prevention of Diabetes and It’s Complications, Hong Kong | 2002-10-01 |
Editorship
| Period | Position | Journal / Conference |
|---|---|---|
| 2021 | Publication Core Committee Member | American Endocrinology Society |
| 2021 | Associate Editor | The Journal of Clinical Endocrinology and Metabolism |
| 2021 | Associate Editor | The Journal of Clinical Endocrinology and Metabolism |
| 2009, 2012, 2016 - 2017, 2019 - 2020 | Associate Editor | Journal of Diabetes Investigation |
| 2019 - 2020 | Associate Editor | The Journal of Clinical Endocrinology & Metabolism |
| 2019 | Editor Board Member | The Journal of Clinical Endocrinology Society |
| 2005, 2018 | Editorial Board Member | Diabetes Research & Clinical Practice |
| 2007, 2018 | Associate Editor | Chinese Journal of Diabetes |
| 2015, 2018 | Editorial Board Member | Journal of Diabetes Investigation |
| 2016, 2018 | Editorial Board Member | Journal of the Endocrine Society |
| 2017 | Editorial Board Member | Endocrinology and Metabolism |
| 2015 - 2016 | Editor in Chief | The Lancet Diabetes & Endocrinology Hong Kong Edition |
| 2015 | Reviewer | Clinical Endocrinology |
| 2013 | Editorial Board Member (2012-16) | Clinical Endocrinology |
| 2007, 2009, 2012 | Associate Editor | Obesity Research & Clinical Practice |
| 2012 | Editorial Board Member | Clinical Endocrinology |
| 2012 | Editorial Board Member | Chinese Journal of Endocrinology and Metabolism |
| 2011 | Regional Editor (2011-2012) | Clinical Obesity |
| 2010 | Associate Editor | Chinese Journal of Endocrinology and Metabolism |
| 2010 | Editorial Board Member (since 2010) | Chinese Journal of Endocrinology and Metabolism |
| 2009 | Associate Editor (2009 – 2013) | Journal of Diabetes Investigation |
| 2005, 2008 | Editorial Board Member | Diabetes, Obesity & Metabolism |
| 2005, 2007 | Associate Editor | Diabetic Medicine |
| 2007 | Associate Editor | Diabetes Research & Clinical Practice |
| 2007 | Associate Editor | The Diabetic Foot |
| 2007 | Associate Editor | Diabetes, Obesity & Metabolism |
| 2006 | Associate Editor (2006-2011) | Obesity Research & Clinical Practice |
| 2003 | Associate Editor (2003 - 2007) | Diabetic Medicine |
| 1998 | Editorial Board Member (since 1998) | Chinese Journal of Diabetes |
| 1998 | Editorial Board Member (1998-2006) | Diabetes, Obesity & Metabolism |
| 1990 | Editorial Board Member (1990-1997) | Biological Signals |
| Since 2010 | Editorial Board Member | Chinese Journal of Endocrinology and Metabolism |
| Since 2001 | Editorial Board Member | The Diabetic Foot Journal |
| Since 1999 | Editorial Board Member | Diabetes Research & Clinical Practice |
| Since 1998 | Editorial Board Member | Chinese Journal of Diabetes |
| 2011 - 2012 | Regional Editor | Clinical Obesity |
| 2009 - 2013 | Associate Editor | Journal of Diabetes Investigation |
| 2006 - 2011 | Associate Editor | Obesity Research & Clinical Practice |
| 2003 - 2007 | Associate Editor | Diabetic Medicine |
| 1998 - 2006 | Editorial Board Member | Diabetes, Obesity & Metabolism |
Community Service
| Start Date | End Date | Position | Type | Title |
|---|---|---|---|---|
| 1992-10-01 | 1994-10-01 | president | O | Hong Kong Society of Endocrinology, Metabolism and Reproduction |
| 2015-08-01 | 2015-08-01 | advisory board member | O | AstraZeneca |
| 2022-06-01 | 2025-06-01 | board member | O | American Endocrine Society |
| 2008-09-01 | 2010-08-01 | board member | O | Board of Governors, Prince Philip Dental Hospital |
| 2014-12-01 | 2015-12-01 | Scientific National Co-ordinator for Hong Kong | O | Servier Beijing on a mulitcentre, muiltinational study entitled |
| 2014-06-01 | 2047-06-01 | honorary president | O | Diabetes Hongkong |
| 2021-04-01 | 2024-06-01 | committee member | O | American Endocrine Society Publication Core Committee |
| 2012-10-01 | 2014-10-01 | member of council | O | Diabetes Hongkong |
| 2015-08-01 | 2016-10-01 | organizing committee member | O | 15th Annual Conference of Chinese Society of Endocrinology (ICE/CSE 2016) |
| 2016-05-01 | 2021-05-01 | expert adviser | O | Chinese Journal of Diabetes |
| 1996-10-01 | 1999-06-01 | Founding President | O | Diabetes Hongkong |
| 2000-01-01 | 2002-01-01 | Member | O | Licentiate Committee, Hong Kong Medical Council |
| 2014-03-01 | 2016-03-01 | expert panel member | O | National Health and Family Planning Commission, China |
| 2006-04-01 | 2015-04-01 | panel member | O | Biology & Medicine Panel, Research Grant Council |
| 2017-05-01 | 2021-06-01 | advisory board member | O | Merck Sharp & Dohme |
| 2013-04-01 | 2018-04-01 | Member | O | Grant Review Board for the Health and Health Services Research Fund, Food and Health Bureau |
| 2013-04-01 | 2015-04-01 | panel member | O | Research Assessment Exercise (RAE), University Grants Committee (UGC) |
| 2015-09-01 | 2016-09-01 | advisory board member | O | AntriaBio, Inc. |
| 2003-01-01 | 2006-01-01 | Member | O | Education Committee, The Hong Kong Academy of Medicine |
| 2018-07-01 | 2020-09-01 | panel member | O | Research Assessment Exercise (RAE), University Grants Committee (UGC) |
| 2012-12-01 | 2016-12-01 | council member | O | Hong Kong Society of Endocrinology, Metabolism and Reproduction |
| 2000-11-01 | 2002-11-01 | council member | O | Hong Kong Society of Endocrinology, Metabolism and Reproduction |
| 1994-10-01 | 1998-10-01 | council member | O | Hong Kong Society of Endocrinology, Metabolism and Reproduction |
| 1988-10-01 | 1990-10-01 | honorary secretary | O | Hong Kong Society of Endocrinology, Metabolism and Reproduction |
| 1991-07-01 | 2017-07-01 | honorary consultant | O | Queen Mary Hospital |
| 2003-01-01 | 2011-01-01 | Member | O | Education and Accreditation Committee, The Medical Council of Hong Kong |
| 2000-01-01 | 2002-01-01 | Chairman | O | Internship Subcommittee, Hong Kong Medical Council |
| 2015-08-01 | 2016-08-01 | committee member | O | Program Organising Committee (POC) of The 17th International Congress of Endocrinology (ICE) |
| 2016-01-01 | 2016-01-01 | advisory board member | O | Takeda China Holdings Co Ltd |
| 2019-10-01 | 2021-09-01 | member | O | Grant Review Board Executive (GRBE), Health and Medicinal Research Fund of the Food and Health Bureau |
| 2004-01-01 | 2007-01-01 | Member | O | Solicitors Disciplinary Tribunal Panel |
| 2013-04-01 | 2022-06-01 | committee member | O | Board of Directors, The Hong Kong Tuberculosis, Chest and Heart Diseases Association |
| 2009-04-01 | 2022-06-01 | board member | O | Board of Directors, The Hong Kong Tuberculosis, Chest and Heart Diseases Association |
| 2010-07-01 | 2021-07-01 | honorary consultant | O | Diabetes Centre, Tung Wah Eastern Hospital |
| 1996-01-01 | 1997-01-01 | panel member | O | Medicine and Biology Panel, The Hong Kong Research Grants Council |
| 2008-02-01 | 2024-02-01 | honorary adviser | O | Association of Hong Kong Diabetes Nurses |
| 1997-01-01 | 1997-12-01 | Member | O | Consumer Council |
| 2000-01-01 | 2002-01-01 | committee member | O | Examination Sub-committee, the Licentiate Committee of The Medical Council of Hong Kong |
| 2004-01-01 | 2014-01-01 | Member | O | Ad-hoc Expert Group on Nutrient Reference Values |
| 2006-01-01 | 2007-01-01 | deputy convenor | O | Health Sciences Panel, Research Assessment Exercise, University Grants Committee |
| 2009-06-01 | 2017-06-01 | committee member | O | Hospital Governing Committee, Grantham Hospital |
| 2022-06-01 | 2025-06-01 | board representative | O | American Endocrine Society Clinical Endocrine Education Committee |
| 2019-10-01 | 2023-10-01 | chairman | O | Grant Review Board (GRB), Health and Medical Research Fund of the Food and Health Bureau |
| 2005-01-01 | 2022-01-01 | reviewer | P | Endocrine Society Annual Meeting Abstract Review |